Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602458 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial for Preventative Scar Management
A NA study, sponsored by Seton Healthcare Family.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01602458: Completed NA study, sponsored by Seton Healthcare Family.
NCT01602458 is a NA study that has completed, run by Seton Healthcare Family. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01602458, a NA study, has completed, sponsored by Seton Healthcare Family.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The study's objective is to compare the global scar outcomes in those treated with silicone only therapy (SOT) versus silicone pressure garment therapy (SPGT) for the prevention of hypertrophic scarring in children with skin grafts after traumatic skin injury.
Primary Outcome
This scale incorporates the patient's/caregiver's perspective on their scar. It measures scar color, pliability, thickness, relief, itching, and pain scored by patient/caregiver. The observer scale measures vascularization, pigmentation, pliability, thickness, and relief.
Interventions
- PROCEDURE Silicone Only Therapy (SOT)
- PROCEDURE Silicone Pressure Garment Therapy (SPGT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01602458 record still lists
NCT01602458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Silicone Only Therapy (SOT) is the first listed.
NCT01602458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01602458 about?
NCT01602458 is a clinical study titled "A Randomized Control Trial for Preventative Scar Management". The study's objective is to compare the global scar outcomes in those treated with silicone only therapy (SOT) versus silicone pressure garment therapy (SPGT) for the prevention of hypertrophic scarring in children with skin grafts after traumatic skin injury.
What is the current status of trial NCT01602458?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2011-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01602458?
The interventions under investigation include: Silicone Only Therapy (SOT) (PROCEDURE), Silicone Pressure Garment Therapy (SPGT) (PROCEDURE).
Who is sponsoring clinical trial NCT01602458?
This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01602458's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia